Epidemiological Study of the Covid-19 Presto Test - The "COVIDOR" Study
NCT ID: NCT04387968
Last Updated: 2021-10-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3228 participants
OBSERVATIONAL
2020-08-24
2021-10-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen
NCT04707833
COVID-19 Prevalence in UNIVI Geriatric Institutions: Epidemiological Study of Immunological Status With Rapid Serological Tests
NCT04790994
Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection
NCT04750720
COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease
NCT04511949
Monitoring of the Post-vaccination Immune Response to COVID-19 Among Hospital Staff
NCT04896788
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The global covid-19 pandemic has affected France and the Loiret, the sarscov-2 coronavirus, has infected several thousand people. On May 7, 2020, there were 75 deaths at the CHRO hospital in Orleans, excluding EHPAD. The contamination rate of the population of the Loiret department has been estimated at 5.6% of the population by Public Health France. This rate is very low and does not allow the use of serological screening tests because of too many false positives or false negatives, there should be a prevalence of the disease greater than 60%. The French health authorities do not recommend the use of a screening test at the present time in view of the uncertainties of the results of this test. The Loiret Management Center, the Department and Orléans Métropole have decided to offer a covid-19 serological screening test, the covid-19 presto test, to voluntary territorial agents regardless of their return to work following the national "deconfinement "on May 11, 2020 This can only be done through an epidemiological surveillance study validated as part of a research protocol.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
agents in contact with the public
patients working with children, policemen, desk office
Covid-19 presto test
Use an auto-test in 15 minutes get the results about covid-19 anticorps
agents with no contact with the public
administrative workers
Covid-19 presto test
Use an auto-test in 15 minutes get the results about covid-19 anticorps
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Covid-19 presto test
Use an auto-test in 15 minutes get the results about covid-19 anticorps
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Volunteer to get tested
Exclusion Criteria
* Covid-19 disease
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
François Rabelais University
UNKNOWN
Assistance Publique - Hôpitaux de Paris
OTHER
University Hospital, Paris
OTHER
Raphael Serreau
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Raphael Serreau
Dr Raphaël SERREAU (PH)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr Raphael SERREAU, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Orleans Metropole
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Unité de Recherche PARADICT-O - Orléans
Orléans, , France
Unité de Recherche PARADICT-O - Service de Médecine - Orléans Métropole
Orléans, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hanane G, Amine Z, Roomila N, Prazuck T, Amirouche A, Olivier V, Benyamina A, Serreau R. COVID-19 seroprevalence among local authority workers from Orleans Metropole, the Community of Communes of the Terres du Val de Loire, the local public service management centre of the Loiret department and the Region Centre Val de Loire: a prospective epidemiological study. BMJ Open. 2023 May 22;13(5):e066504. doi: 10.1136/bmjopen-2022-066504.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A01414-35
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.